I. Introduction
Diabetes Mellitus refers to the group of common metabolic disorders that share the phenotype of hyperglycemia with an increasing incidence worldwide 1 . Diabetes Mellitus will be a leading cause of morbidity and mortality. The prevalence of Diabetes Mellitus is rising rapidly in India presumably because of increase obesity, decrease activity levels and industrialization. HbA1c which was primary used to test glycemic control has now been added as a diagnostic tool, therefore it is more important today than earlier 2 . HbA1c levels are not affected by blood sugar levels alone. Any condition that shortens the life span of erythrocytes is likely to decrease the HbA1c level. Iron and Vitamin B12 deficiency, renal failure and bone marrow suppression in alcoholism inhibit erythropoiesis and increase the mean survival of erythrocytes, leading to increase in HbA1c level.However, hemolytic anemia, chronic liver disease, and increased hemolysis from splenomegaly increase reticuloyte and decrease the mean age of erythrocyte, which can decrease HbA 1c level. 3 Since Vitamin B12 deficiency affects erythropoiesis and is itself cause of anemia it is likely that HbA1c level will be affected in Vitamin B12 deficiency anemia.
II.

Methods
The study was conducted in tertiary care hospital Mahatma Gandhi Medical College and Hospital, Jaipur in the patients admitted in the medicine wards. It included 90 participants with 30 patients having iron deficiency anemia, 30 with Vitamin B12 deficiency anemia and rest 30 belong to the control group. All the patients were screened for Fasting Blood Sugar, Renal Function, Hematological parameters and those with Fasting Plasma Glucose < 100 mg/dl were classified into having iron deficiency anemia, vitamin B12 deficiency anemia and controls without anemia. HbA1c was measured in each group and as compared using ANOVA and T test analysis.
The data was recorded for all the eligible patients on a predesigned proforma and analyzed. The data will be presented as Mean±SD for continuous variables. A Student's t-test will be applied for comparison of group 
Results
During the period of study 90 patients were screened and out of which 30 were of iron deficiency anemia, 30 of vitamin B12 deficiency anemia and 30 were control. The mean age distribution of participants in Iron deficiency anemia was 36.27+7.282, Vitamin B 12 deficiency group was 37.23+6.218 and control group was 38.10+7.112.
Out of 30 participants in each group, 11 participants (36.67%) were male and 19 participants (63.335%) were female in iron deficiency group, 16 (53.33%) were male and 14 (46.67%) were female in vitamin B12 deficiency group , 18 (60%) were male and 12(40%) were female in control group. The Mean Hb in Group 1(Iron deficiency Anemia) was 7.82+1.28, In Group 2 (Vitamin B 12 deficiency anemia) was 7.45+1.46, and in Group 3 (Control) 13.21+0.80. In Iron deficiency anemia 14 patients had moderate anemia and 16 patients had severe anemia. In Vitamin B 12 Deficiency group 9 patients belonged to moderate anemia and 21 patients belonged to severe anemia group. The mean HbA1c levels in iron deficiency anemia group was 5.61+0.69, in Vitamin B12 deficiency was 5.50+0.39 and in control group was 5+0.32. The mean HBa1c value of both iron deficiency anemia and Vitamin B 12 deficiency anemia were more compared to control group and this difference was found to be statistically significant.
In Iron deficiency anemia 10 out of 30 participants (33.33%) had Hba 1c in the range of impaired glucose homeostasis(5.6 -6.5) 2 and in Vitamin B12 deficiency anemia 12 out of 30 participants (40%) had Hba 1c in the range of impaired glucose homeostasis. Interestingly 2 patients from iron 
IV. Discussion
Hemoglobin A 1c which has been included as a diagnostic tool for the diagnosis of Diabetes in American Diabetes Association criteria 2011 will now play an important role in diagnosis and treatment of Diabetes mellitus. 4 However several factors other than blood sugar can alter the HbA 1c levels are blood loss 5 In the control group, 12 participants (40%) were female and 18 (60%) were male. This sample size was adequately matched with the studies conducted earlier. The mean age of the patients of IDA was 36.27 yr and that of Vitamin B12 deficiency anemia was 37.23 yr. The mean age of the control participants was 38.10 yr. In Iron deficiency anemia 14 patients had moderate anemia and 16 patients had severe anemia. In Vitamin B 12 Deficiency group 9 patients belonged to moderate anemia and 21 patients belonged to severe anemia group. We found no cases of mild anemia.
Our results suggested that IDA was associated with higher concentrations of HbA 1c . It was found that the mean values of HbA 1c in Iron deficiency group weresignificantly higher (5.61%) compared to that of control group where it was 5.00%. This difference was found to be significant (P < 0.001.) on statistical testing. Our study also revealed that the difference in mean HbA 1c levels of severely anemic patients (6.04%) and moderately anemic patients (5.11%) was statistically significant (p<0.001).
Although prolongation of erythrocyte survival in patients with IDA is known to elevate the HbA 1c level, some studies have shown normal or even shortened lifespans of erythrocytes in patients with IDA. In study by Sinha et al (2012) 8 the HbA 1c levels were found to be significantly lower in patients with iron deficiency anemia than in the controls. Moreover, the HbA 1c levels increased after treatment, which had not been reported in any previous study. The absolute HbA 1c levels, which were significantly lower in patients than in controls, were also found to increase significantly after iron treatment. The hemoglobin and HbA 1c levels were positively correlated in anemia patients before treatment, but no positive correlation was apparent at 2 months after treatment. The authors did not discuss why their data conflicts with other studies but Emma English et al.(2015) 9 in the review article postulated that it may be due to the severity of anemia as the participants in this study had low mean hemoglobin levels(62g/dl); the duration of anemia was not given. But in our study patients with severe anemia had significantly higher HbA 1c levels compared to patients with moderate anemia as well as controls.
The present study observed that 10 cases of Iron Deficiency Anemia and 12 cases of Vitamin B 12 deficiency anemia cases fell into impaired glucose homeostasiscategory and 2 patients of Iron Deficiency Anemia fell into diabetic category according to American Diabetes Association 2011 criteria even while their fasting sugars were normal. This agrees with Hardikar et al (2012) 10 who investigated a population where 34% were anemic, 37% were iron deficient, 40% were vitamin B 12 deficient, and 22% were folate deficient. Only 20% of those diagnosed as prediabetic and diabetic by HbA 1c had prediabetes and diabetes according to the OGTT, and among the anemic, this figure was only 7%. In this young, apparently healthy, and non-diabetic group, 2-h glucose concentrations explained only 25.6% of the variance in HbA 1c concentrations and hematological parameters contributed up to 13.1%, leaving over half of the variance unexplained. They concluded that use of HbA 1c to diagnose prediabetes and diabetes in iron-deficient populations may lead to a spuriously exaggerated prevalence of prediabetes.
This study has got a significant relevance because Iron and Vitamin B12 deficiency anemia is very highly prevalent in a tropical country like India. Iron and Vitamin B12 deficiency anemia being common variables, influences the HbA 1c levels when they are estimated by the most commonly employed methods like immunoturbidometry and so, they must be corrected before making any diagnostic or therapeutic decision based on the HbA 1c levels. HbA 1c is commonly used to assess the long-term blood glucose control in the patients with diabetes mellitus, because the HbA 1c value has been shown to predict the risk for the development of many of the chronic complications in diabetes.
